Ambu aScope Gastro; Ambu aScope Gastro Large
Ambu A/S · Decision date Sep 16, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 16, 2026 for K261400, a traditional 510(k) submitted by Ambu A/S of Ballerup, Denmark, covering the Ambu® aScope™ Gastro and Ambu® aScope™ Gastro Large. The device falls under 21 CFR 876.1500 (Endoscope And Accessories), Class II, with classification product code FDS and subsequent product code FAM, in the Gastroenterology/Urology panel. Substantial equivalence is a marketing clearance, not premarket approval.
The FDA letter is addressed to Ambu, Inc. in Columbia, Maryland, care of correspondent Sanjay Parikh, and states the agency reviewed the notification against legally marketed predicate devices. The public record does not describe the specific components, design changes or performance data supporting the clearance, and the indications for use appear only in an enclosure not included in the available text. No clinical or comparative performance conclusions can be drawn from these records.
The database entry lists a receipt date of April 29, 2026, while the letter cites a dated and received date of August 14, 2026; the discrepancy is unresolved in the source. The submission was not reviewed by a third party, is not a combination product, and no predetermined change control plan was authorized.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Sep 16, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261400
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Ambu A/S
- Product code
- FDS
- Decision code
- SESE
- Decision date
- Sep 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Gastroscope And Accessories, Flexible/Rigid.
FDA decision timeline
K261400 received
Application receipt date recorded by FDA.
K261400 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Ambu A/S
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Ballerup
Sources and methodology
- Original FDA record: K261400
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records